CBP Rules Medical Devices May Not be Removed from FTZ for Sterilization
Disposable medical devices produced by Becton Dickinson Infusion Therapy Systems (BD) may not be temporarily removed from a foreign trade zone (FTZ) for sterilization, said CBP in a June 21 ruling. The ruling came in response to a request on behalf of BD that CBP determine whether or not BD could temporarily remove devices such as needles, syringes, catheters and cannulas from a FTZ for sterilization purposes without entering the devices for consumption.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
CBP only permits the temporary removal of products from a zone if “the processing does not constitute manufacturing or production and no value is added to the merchandise,” the ruling said. BD argued that sterilization was not a manufacture because none of the processes required any physical change to the devices, only killing unwanted microbes. BD also argued that the 3 percent increase of standard cost applicable to the sterilization should be “considered a de minimis increase in value.”
However, CBP determined that the unsterilized medical devices at hand are contaminated by microbes and would be “wholly unfit” for their intended uses, including “insertion into a body cavity, surgical suturing and injecting fluids into the body.” Under one of the agency’s long-standing definitions, manufacture or production is an operation that “renders a commodity of articles fit for use for which it was otherwise unfit.” The sterilization process renders the imported medical devices as fit for use and consequently can be defined as a manufacture.